Usage and impact of patient-reported outcomes in epilepsy

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Usage and impact of patient-reported outcomes in epilepsy. / Vonck, Kristl; Biraben, Arnaud; Bosak, Magdalena; Jennum, Poul Jørgen; Kimiskidis, Vasilios K.; Marusic, Petr; Mitchell, James W.; Ferreira, Lara N.; Ondrušová, Martina; Pana, Adrian; Persson, Ulf; von Oertzen, Tim J.; Lattanzi, Simona.

In: Brain and Behavior, Vol. 13, No. 12, e3342, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Vonck, K, Biraben, A, Bosak, M, Jennum, PJ, Kimiskidis, VK, Marusic, P, Mitchell, JW, Ferreira, LN, Ondrušová, M, Pana, A, Persson, U, von Oertzen, TJ & Lattanzi, S 2023, 'Usage and impact of patient-reported outcomes in epilepsy', Brain and Behavior, vol. 13, no. 12, e3342. https://doi.org/10.1002/brb3.3342

APA

Vonck, K., Biraben, A., Bosak, M., Jennum, P. J., Kimiskidis, V. K., Marusic, P., Mitchell, J. W., Ferreira, L. N., Ondrušová, M., Pana, A., Persson, U., von Oertzen, T. J., & Lattanzi, S. (2023). Usage and impact of patient-reported outcomes in epilepsy. Brain and Behavior, 13(12), [e3342]. https://doi.org/10.1002/brb3.3342

Vancouver

Vonck K, Biraben A, Bosak M, Jennum PJ, Kimiskidis VK, Marusic P et al. Usage and impact of patient-reported outcomes in epilepsy. Brain and Behavior. 2023;13(12). e3342. https://doi.org/10.1002/brb3.3342

Author

Vonck, Kristl ; Biraben, Arnaud ; Bosak, Magdalena ; Jennum, Poul Jørgen ; Kimiskidis, Vasilios K. ; Marusic, Petr ; Mitchell, James W. ; Ferreira, Lara N. ; Ondrušová, Martina ; Pana, Adrian ; Persson, Ulf ; von Oertzen, Tim J. ; Lattanzi, Simona. / Usage and impact of patient-reported outcomes in epilepsy. In: Brain and Behavior. 2023 ; Vol. 13, No. 12.

Bibtex

@article{18a7ff0ee3df465d8cd4df1e3ab2236f,
title = "Usage and impact of patient-reported outcomes in epilepsy",
abstract = "Background: The use of patient-reported outcomes (PRO) in clinical practice is gaining increasing attention. This study aimed to provide a critical assessment of the current state-of-the-art and beliefs about the use of PRO in the management of people with epilepsy across some European countries. Methods: Structured interviews were conducted with European experts to collect insights about (I) the personal experience with PRO; (II) the value and impact of PRO in the decision-making process at the national level; and (III) the interest for and use of PRO by national health authorities. Results: Nine neurologists (Austria, Belgium, Czechia, Denmark, France, Greece, Italy, Poland, and United Kingdom), three health economists (Portugal, Romania, and Sweden), and one epidemiologist (Slovakia) participated. They all stated that PRO are collected at their own countries in the context of clinical trials and/or specific projects. During everyday clinical practice, PRO are collected routinely/almost routinely in Austria and Sweden and only at the discretion of the treating physicians in Czechia, Denmark, France, Greece, and Portugal. There was complete consensus about the favorable impact that the PRO can have in terms of clinical outcomes, healthcare resources utilization, and general patient satisfaction. Only participants from Portugal and Sweden answered that the PRO are perceived as very important by the National Health Authorities of their respective countries. Conclusions: Differences exist in attitudes and perspectives about PRO in epilepsy across Europe. An active plan is warranted to harmonize the measurement of PRO and ensure they can be relevant to people with epilepsy and health services.",
keywords = "economics, epilepsy, patient-reported outcomes, seizure",
author = "Kristl Vonck and Arnaud Biraben and Magdalena Bosak and Jennum, {Poul J{\o}rgen} and Kimiskidis, {Vasilios K.} and Petr Marusic and Mitchell, {James W.} and Ferreira, {Lara N.} and Martina Ondru{\v s}ov{\'a} and Adrian Pana and Ulf Persson and {von Oertzen}, {Tim J.} and Simona Lattanzi",
note = "Publisher Copyright: {\textcopyright} 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC.",
year = "2023",
doi = "10.1002/brb3.3342",
language = "English",
volume = "13",
journal = "Brain and Behavior",
issn = "2157-9032",
publisher = "JohnWiley & Sons Ltd",
number = "12",

}

RIS

TY - JOUR

T1 - Usage and impact of patient-reported outcomes in epilepsy

AU - Vonck, Kristl

AU - Biraben, Arnaud

AU - Bosak, Magdalena

AU - Jennum, Poul Jørgen

AU - Kimiskidis, Vasilios K.

AU - Marusic, Petr

AU - Mitchell, James W.

AU - Ferreira, Lara N.

AU - Ondrušová, Martina

AU - Pana, Adrian

AU - Persson, Ulf

AU - von Oertzen, Tim J.

AU - Lattanzi, Simona

N1 - Publisher Copyright: © 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

PY - 2023

Y1 - 2023

N2 - Background: The use of patient-reported outcomes (PRO) in clinical practice is gaining increasing attention. This study aimed to provide a critical assessment of the current state-of-the-art and beliefs about the use of PRO in the management of people with epilepsy across some European countries. Methods: Structured interviews were conducted with European experts to collect insights about (I) the personal experience with PRO; (II) the value and impact of PRO in the decision-making process at the national level; and (III) the interest for and use of PRO by national health authorities. Results: Nine neurologists (Austria, Belgium, Czechia, Denmark, France, Greece, Italy, Poland, and United Kingdom), three health economists (Portugal, Romania, and Sweden), and one epidemiologist (Slovakia) participated. They all stated that PRO are collected at their own countries in the context of clinical trials and/or specific projects. During everyday clinical practice, PRO are collected routinely/almost routinely in Austria and Sweden and only at the discretion of the treating physicians in Czechia, Denmark, France, Greece, and Portugal. There was complete consensus about the favorable impact that the PRO can have in terms of clinical outcomes, healthcare resources utilization, and general patient satisfaction. Only participants from Portugal and Sweden answered that the PRO are perceived as very important by the National Health Authorities of their respective countries. Conclusions: Differences exist in attitudes and perspectives about PRO in epilepsy across Europe. An active plan is warranted to harmonize the measurement of PRO and ensure they can be relevant to people with epilepsy and health services.

AB - Background: The use of patient-reported outcomes (PRO) in clinical practice is gaining increasing attention. This study aimed to provide a critical assessment of the current state-of-the-art and beliefs about the use of PRO in the management of people with epilepsy across some European countries. Methods: Structured interviews were conducted with European experts to collect insights about (I) the personal experience with PRO; (II) the value and impact of PRO in the decision-making process at the national level; and (III) the interest for and use of PRO by national health authorities. Results: Nine neurologists (Austria, Belgium, Czechia, Denmark, France, Greece, Italy, Poland, and United Kingdom), three health economists (Portugal, Romania, and Sweden), and one epidemiologist (Slovakia) participated. They all stated that PRO are collected at their own countries in the context of clinical trials and/or specific projects. During everyday clinical practice, PRO are collected routinely/almost routinely in Austria and Sweden and only at the discretion of the treating physicians in Czechia, Denmark, France, Greece, and Portugal. There was complete consensus about the favorable impact that the PRO can have in terms of clinical outcomes, healthcare resources utilization, and general patient satisfaction. Only participants from Portugal and Sweden answered that the PRO are perceived as very important by the National Health Authorities of their respective countries. Conclusions: Differences exist in attitudes and perspectives about PRO in epilepsy across Europe. An active plan is warranted to harmonize the measurement of PRO and ensure they can be relevant to people with epilepsy and health services.

KW - economics

KW - epilepsy

KW - patient-reported outcomes

KW - seizure

U2 - 10.1002/brb3.3342

DO - 10.1002/brb3.3342

M3 - Journal article

C2 - 37997564

AN - SCOPUS:85177578105

VL - 13

JO - Brain and Behavior

JF - Brain and Behavior

SN - 2157-9032

IS - 12

M1 - e3342

ER -

ID: 396015345